Literature DB >> 2645525

Involvement of the 'leucine zipper' region in the oligomerization and transforming activity of human c-myc protein.

C V Dang1, M McGuire, M Buckmire, W M Lee.   

Abstract

c-Myc plays a part in the regulation of important cellular processes such as growth, differentiation and neoplastic transformation. Although c-myc gene structure and expression are well characterized, the function and biochemical properties of the protein are less well understood. Human c-myc is a 439-amino acid phosphoprotein which binds DNA in vitro and belongs to a discrete subset of nuclear proteins. Using the human c-myc mutants generated by linker-insertion and deletion mutagenesis, we have defined regions of the protein that are important for its transforming activities and its nuclear localization. Here, we show that human c-myc exists as an oligomer in vitro and use mutant proteins to localize the oligomerization domain to a carboxyl-terminal peptide containing the 'leucine zipper' motif. The 'leucine zipper' describes a structure found in a number of DNA-binding proteins that contains leucines occurring at intervals of every seventh amino acid in a region predicted to be alpha-helical. The 'leucine zipper' might mediate dimerization by intermolecular interdigitation of the leucine side-chains. We show that a c-myc mutant, which is inactive but can oligomerize, dominantly inhibits the cotransforming activity with wild-type c-myc of rat embryo cells, whereas inactive mutants which cannot oligomerize properly because of deletions in the oligomerization domain are recessive.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645525     DOI: 10.1038/337664a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  72 in total

1.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription.

Authors:  G J Kato; J Barrett; M Villa-Garcia; C V Dang
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  A point mutation in the MyoD basic domain imparts c-Myc-like properties.

Authors:  M E Van Antwerp; D G Chen; C Chang; E V Prochownik
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

3.  Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen.

Authors:  Y P Xia; M M Lai
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.

Authors:  Asya V Grinberg; Chang-Deng Hu; Tom K Kerppola
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

5.  The centromere and promoter factor 1 of yeast contains a dimerisation domain located carboxy-terminal to the bHLH domain.

Authors:  S J Dowell; J S Tsang; J Mellor
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

6.  The leucine zipper of c-Myc is required for full inhibition of erythroleukemia differentiation.

Authors:  M J Smith; D C Charron-Prochownik; E V Prochownik
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

7.  Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping.

Authors:  L J Penn; M W Brooks; E M Laufer; T D Littlewood; J P Morgenstern; G I Evan; W M Lee; H Land
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

8.  Transcriptional suppression of cellular gene expression by c-Myc.

Authors:  B S Yang; T J Geddes; R J Pogulis; B de Crombrugghe; S O Freytag
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

9.  Trans-dominant negative mutants of Fos and Jun.

Authors:  L J Ransone; J Visvader; P Wamsley; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

10.  Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.

Authors:  Z Dong; M J Birrer; R G Watts; L M Matrisian; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.